O Shaughnessy Asset Management LLC boosted its stake in Relx Plc (NYSE:RELX - Free Report) by 5.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 407,376 shares of the technology company's stock after acquiring an additional 21,040 shares during the period. O Shaughnessy Asset Management LLC's holdings in Relx were worth $18,503,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in RELX. FMR LLC raised its position in Relx by 8.3% during the 3rd quarter. FMR LLC now owns 7,148,837 shares of the technology company's stock worth $339,284,000 after buying an additional 548,423 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its holdings in Relx by 50.3% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,968,739 shares of the technology company's stock worth $89,420,000 after purchasing an additional 658,655 shares in the last quarter. Natixis Advisors LLC lifted its position in Relx by 2.8% in the fourth quarter. Natixis Advisors LLC now owns 1,202,592 shares of the technology company's stock valued at $54,622,000 after purchasing an additional 32,739 shares during the period. Raymond James Financial Inc. purchased a new stake in Relx in the 4th quarter valued at approximately $44,516,000. Finally, JPMorgan Chase & Co. increased its position in Relx by 14.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 826,481 shares of the technology company's stock worth $39,225,000 after purchasing an additional 104,999 shares during the period. 15.02% of the stock is owned by hedge funds and other institutional investors.
Relx Price Performance
NYSE RELX traded up $0.26 during mid-day trading on Tuesday, hitting $50.67. The stock had a trading volume of 402,553 shares, compared to its average volume of 754,648. The company has a 50 day simple moving average of $49.55 and a 200 day simple moving average of $47.87. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. The company has a market cap of $94.05 billion, a price-to-earnings ratio of 27.24, a P/E/G ratio of 2.73 and a beta of 0.90. Relx Plc has a 52-week low of $40.25 and a 52-week high of $51.99.
Relx Increases Dividend
The company also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Friday, May 9th will be paid a dividend of $0.5586 per share. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, May 9th. This is an increase from Relx's previous semi-annual dividend of $0.23. Relx's payout ratio is 59.68%.
Wall Street Analyst Weigh In
A number of analysts recently weighed in on the company. The Goldman Sachs Group began coverage on Relx in a research note on Wednesday, March 26th. They issued a "buy" rating on the stock. StockNews.com lowered shares of Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. Barclays upgraded shares of Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. Finally, Redburn Atlantic began coverage on shares of Relx in a report on Wednesday, January 8th. They set a "buy" rating on the stock. One equities research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Buy".
Check Out Our Latest Stock Analysis on Relx
About Relx
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
See Also
Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
